San Francisco Chronicle Bay Area - Spoken Edition

Berkeley boy was ‘Patient X’ in first FDA-approved medicine derived from marijuana

07.12.2018 - By San Francisco ChroniclePlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Dr. Maria Roberta Cilio of UCSF conducted the clinical trial that included Sam and led to FDA approval of Epidiolex. Sam, with his life back after using cannabidiol, watches a show on his phone at his home. Sam Vogelstein, 17, plays with Maisy at his home in Berkeley. He was the first person to use cannabidiol to control epilepsy. The Berkeley boy had his first epileptic seizure when he was 4, and after that, they kept coming, up to 100 a day.

More episodes from San Francisco Chronicle Bay Area - Spoken Edition